Welsh, Carson, Anderson & Stowe

WCAS concentrates exclusively on two sectors: technology and healthcare. Within those, the firm pursues buyouts, growth equity, and recapitalizations, typically partnering with management teams to drive organic growth and acquisition strategies. This dual-sector mandate has remained consistent across all 18 of its funds.

WCAS executes both control buyouts and growth-stage investments, along with recapitalizations. The firm's public positioning emphasizes forming deep partnerships with management teams, which can apply to minority or majority stakes depending on the opportunity and the management team's objectives.

Known portfolio companies span enterprise software, government IT, and supply-chain technology. Confirmed holdings include Absorb Software, a learning management system; GovCIO, a federal IT services provider; and TrueCommerce, a supply-chain connectivity platform. In healthcare, the firm's exit of Lumexa Imaging via IPO in late 2025 signals continued deal activity in medical technology.

WCAS maintains separate origination channels for technology and healthcare, each with a dedicated email contact for potential investments. The 46-year franchise and deep networks within these two verticals likely produce proprietary deal flow through relationships with industry executives, sector-focused intermediaries, and repeat management partners.

WCAS does not publicly list its managing partners or investment committee members on its website. The only principal named publicly is Gene Lockhart, who joined as an operating partner in September 2025. The firm's day-to-day investment leadership is not disclosed in accessible primary sources.